Error: Could not add to watchlist. X
+ Watchlist

Vaxil Bio Ltd/Israel

SEEEF:US
OTC US
Price not available for SEEEF:US
USD
Volume
0
Previous Close
0.15
52Wk Range
0.02 - 0.22
Volume
0
Previous Close
0.15
52Wk Range
0.02 - 0.22
Current P/E Ratio (TTM)
-
Earnings per Share (ILS) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
30.057
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Vaxil Bio Limited is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology.
Address
Bl 13A, 13 Einstein st.
Weizmann Science Park
Nes Ziona, 74036
Israel
Phone
972-8-939-6948
Show More